Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
36
ENTA Quote, Financials, Valuation and Earnings
Last price:
$5.89
Seasonality move
:
-2.91%
Day range:
$5.84 - $6.10
52-week range:
$4.09 - $17.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.00x
P/B ratio:
1.39x
Volume:
148.3K
Avg. volume:
194.2K
1-year change:
-51.32%
Market cap:
$129.8M
Revenue:
$67.6M
EPS (TTM):
-$4.54
Earnings Data
Next earnings date for ENTA
Aug 05
2025
Most recent earnings per share
-$1.06
Beat by $0.08
(May 12/2025)
Consensus Estimate
-$1.14
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ENTA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/05/2025 | Q2 | $16.2M | -- | -- | -$0.81 | -- |
| 05/12/2025 | Q1 | $16M | $14.9M | -$1.06 | -$1.14 | $0.08 |
| 02/10/2025 | Q4 | $17.2M | $17M | -$1.05 | -$1.35 | $0.30 |
| 11/25/2024 | Q3 | $17.8M | $14.6M | -$1.36 | -$0.92 | -$0.44 |
| 08/05/2024 | Q2 | $17.2M | $18M | -$1.07 | -$1.41 | $0.34 |
| 05/06/2024 | Q1 | $16.2M | $17.1M | -$1.47 | -$1.40 | -$0.07 |
| 02/07/2024 | Q4 | $21.9M | $18M | -$1.58 | -$1.23 | -$0.35 |
| 11/20/2023 | Q3 | -- | -- | -$1.33 | -$2.21 | $0.88 |
| 08/07/2023 | Q2 | -- | -- | -$1.86 | -$2.19 | $0.33 |
| 05/08/2023 | Q1 | -- | -- | -$1.79 | -$1.93 | $0.14 |
| 02/07/2023 | Q4 | -- | -- | -$1.39 | -$1.60 | $0.21 |
| 11/21/2022 | Q3 | -- | -- | -$1.27 | -$1.35 | $0.08 |
| 08/08/2022 | Q2 | -- | -- | -$1.53 | -$1.39 | -$0.14 |
| 05/09/2022 | Q1 | -- | -- | -$1.63 | -$1.41 | -$0.22 |
| 02/08/2022 | Q4 | -- | -- | -$1.48 | -$1.11 | -$0.37 |
| 11/22/2021 | Q3 | -- | -- | -$1.22 | -$1.19 | -$0.03 |
| 08/05/2021 | Q2 | -- | -- | -$1.19 | -$1.29 | $0.10 |
| 05/06/2021 | Q1 | -- | -- | -$1.09 | -$0.97 | -$0.12 |
| 02/08/2021 | Q4 | -- | -- | -$0.41 | -$0.77 | $0.36 |
| 11/23/2020 | Q3 | -- | -- | -$1.46 | -$0.97 | -$0.49 |
| 08/04/2020 | Q2 | -- | -- | -$0.71 | -$0.96 | $0.25 |
| 05/06/2020 | Q1 | -- | -- | -$0.30 | -$0.72 | $0.42 |
| 02/06/2020 | Q4 | -- | -- | $0.65 | $0.60 | $0.05 |
| 11/21/2019 | Q3 | -- | -- | $0.44 | $0.56 | -$0.12 |
| 08/06/2019 | Q2 | -- | -- | $0.33 | $0.17 | $0.16 |
| 05/07/2019 | Q1 | -- | -- | $0.20 | -$0.05 | $0.25 |
| 02/06/2019 | Q4 | -- | -- | $1.25 | -- | -- |
| 11/26/2018 | Q3 | -- | -- | $1.30 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | $0.97 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | $0.61 | -- | -- |
| 02/07/2018 | Q4 | -- | -- | $0.59 | -- | -- |
| 11/20/2017 | Q3 | -- | -- | $1.86 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$0.44 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$0.28 | -- | -- |
| 02/08/2017 | Q4 | -- | -- | -$0.26 | -- | -- |
| 11/21/2016 | Q3 | -- | -- | -$0.09 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.09 | -- | -- |
| 02/08/2016 | Q4 | -- | -- | $1.36 | -- | -- |
| 11/23/2015 | Q3 | -- | -- | $0.29 | -- | -- |
| 08/06/2015 | Q2 | -- | -- | $0.13 | -- | -- |
Enanta Pharmaceuticals Earnings Questions
-
How Much did Enanta Pharmaceuticals Generate in Revenue Last Quarter?
Enanta Pharmaceuticals reported $14.9M worth of top line sales in its most recent quarter.
-
Did Enanta Pharmaceuticals Beat Earnings Last Quarter?
Enanta Pharmaceuticals announced earnings per share of -$1.06 which represents a beat of analyst forecast a -$1.14 per share.
-
Is Enanta Pharmaceuticals Profitable?
Enanta Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Enanta Pharmaceuticals EPS Next Year?
Enanta Pharmaceuticals's earnings are forecast to decrease from -$5.48 per share to -$5.18 per share next year representing a decrease of -28.94%.
-
When is Enanta Pharmaceuticals's Earnings Date?
Enanta Pharmaceuticals's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 8.8% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 0.4% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 0.4% over the past day.
